Zobrazeno 1 - 10 of 701 pro vyhledávání: '"Gamell, C."'
1
Akademický článek
Whole blood transcriptomics reveals granulocyte colony-stimulating factor as a mediator of cardiopulmonary bypass-induced systemic inflammatory response syndrome.
Autor: Martin KR; WEHI Parkville VIC Australia.; Department of Medical Biology University of Melbourne Parkville VIC Australia., Gamell C; CSL Innovation, Bio21 Institute Parkville VIC Australia., Tai TY; WEHI Parkville VIC Australia.; CSL Innovation, Bio21 Institute Parkville VIC Australia., Bonelli R; WEHI Parkville VIC Australia.; Department of Medical Biology University of Melbourne Parkville VIC Australia.; CSL Innovation, Bio21 Institute Parkville VIC Australia., Hansen J; WEHI Parkville VIC Australia., Tatoulis J; Cardiothoracic Surgery Royal Melbourne Hospital Parkville VIC Australia.; Department of Surgery University of Melbourne Parkville VIC Australia., Alhamdoosh M; CSL Innovation, Bio21 Institute Parkville VIC Australia., Wilson N; CSL Innovation, Bio21 Institute Parkville VIC Australia., Wicks I; WEHI Parkville VIC Australia.; Department of Medical Biology University of Melbourne Parkville VIC Australia.; Department of Rheumatology Royal Melbourne Hospital Parkville VIC Australia.
Publikováno v: Clinical & translational immunology [Clin Transl Immunology] 2024 Feb 19; Vol. 13 (2), pp. e1490. Date of Electronic Publication: 2024 Feb 19 (Print Publication: 2024).
Zobrazit plný text záznamu
2
Akademický článek
CSL362 potently and specifically depletes pDCs in vitro and ablates SLE-immune complex-induced IFN responses.
Autor: Monaghan KA; Research and Development, CSL Limited, Melbourne, VIC 3010, Australia., Hoi A; Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Melbourne, VIC 3168, Australia.; Monash Health, Clayton, VIC 3168, Australia., Gamell C; Research and Development, CSL Limited, Melbourne, VIC 3010, Australia., Tai TY; Research and Development, CSL Limited, Melbourne, VIC 3010, Australia., Linggi B; Janssen Research and Development LLC, Spring House, PA 19477, USA., Jordan J; Janssen Research and Development LLC, Spring House, PA 19477, USA., Cesaroni M; Janssen Research and Development LLC, Spring House, PA 19477, USA., Sato T; Janssen Research and Development LLC, Spring House, PA 19477, USA., Ng M; Research and Development, CSL Limited, Melbourne, VIC 3010, Australia., Oon S; The Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia.; The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.; The University of Melbourne Parkville, Parkville, VIC 3010, Australia., Benson J; Janssen Research and Development LLC, Spring House, PA 19477, USA., Wicks I; The Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia.; The Royal Melbourne Hospital, Parkville, VIC 3050, Australia.; The University of Melbourne Parkville, Parkville, VIC 3010, Australia., Morand E; Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Melbourne, VIC 3168, Australia.; Monash Health, Clayton, VIC 3168, Australia., Wilson N; Research and Development, CSL Limited, Melbourne, VIC 3010, Australia.
Publikováno v: IScience [iScience] 2023 Jun 20; Vol. 26 (7), pp. 107173. Date of Electronic Publication: 2023 Jun 20 (Print Publication: 2023).
Zobrazit plný text záznamu
3
Akademický článek
CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa.
Autor: Gamell C; CSL Innovation, Melbourne, VIC 3052, Australia., Bankovacki A; CSL Innovation, Melbourne, VIC 3052, Australia., Scalzo-Inguanti K; CSL Innovation, Melbourne, VIC 3052, Australia., Sedgmen B; CSL Innovation, Melbourne, VIC 3052, Australia., Alhamdoosh M; CSL Innovation, Melbourne, VIC 3052, Australia., Gail E; CSL Innovation, Melbourne, VIC 3052, Australia., Turkovic L; CSL Innovation, Melbourne, VIC 3052, Australia., Millar C; CSL Innovation, Melbourne, VIC 3052, Australia., Johnson L; CSL Innovation, Melbourne, VIC 3052, Australia., Wahlsten M; MD Biosciences, aka MLM Medical Labs Minnesota, Inc., Oakdale, MN 55128, USA., Richter J; MD Biosciences, aka MLM Medical Labs Minnesota, Inc., Oakdale, MN 55128, USA., Schuster J; MD Biosciences, aka MLM Medical Labs Minnesota, Inc., Oakdale, MN 55128, USA., Dyson A; CSL Innovation, Melbourne, VIC 3052, Australia., Nicolopoulos J; Dermatology Department, Royal Melbourne Hospital, Parkville, VIC 3050, Australia., Varigos G; Dermatology Department, Royal Melbourne Hospital, Parkville, VIC 3050, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Carlton VIC, Australia., Ng M; CSL Innovation, Melbourne, VIC 3052, Australia., Wilson N; CSL Innovation, Melbourne, VIC 3052, Australia., Field J; CSL Innovation, Melbourne, VIC 3052, Australia., Kern JS; Dermatology Department, Royal Melbourne Hospital, Parkville, VIC 3050, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Carlton VIC, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Dermatology, Alfred Hospital, Melbourne, VIC, Australia., Lindqvist LM; CSL Innovation, Melbourne, VIC 3052, Australia.
Publikováno v: The British journal of dermatology [Br J Dermatol] 2023 Apr 20; Vol. 188 (5), pp. 636-648.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.
Autor: Mejía-Hernández JO; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Raghu D; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.; Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Heidelberg, VIC 3084, Australia., Caramia F; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Clemons N; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Fujihara K; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Riseborough T; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Teunisse A; Department of Cell and Chemical Biology, Leiden University Medical Centre, 2333 Leiden, The Netherlands., Jochemsen AG; Department of Cell and Chemical Biology, Leiden University Medical Centre, 2333 Leiden, The Netherlands., Abrahmsén L; Aprea Therapeutics AB, 17165 Stockholm, Sweden., Blandino G; Translational Oncology Research Unit, IRCSS Regina Elena National Cancer Institute, 0144 Rome, Italy., Russo A; Surgical Pathology Unit, Department of Research, Advanced Diagnostics and Technological Innovation, IRCSS Regina Elena National Cancer Institute, 0144 Rome, Italy., Gamell C; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Fox SB; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.; Pathology Department, Peter MacCallum Cancer Centre, Parkville, VIC 3000, Australia., Mitchell C; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Pathology Department, Peter MacCallum Cancer Centre, Parkville, VIC 3000, Australia., Takano EA; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Pathology Department, Peter MacCallum Cancer Centre, Parkville, VIC 3000, Australia., Byrne D; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Pathology Department, Peter MacCallum Cancer Centre, Parkville, VIC 3000, Australia., Miranda PJ; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Saleh R; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Thorne H; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Sandhu S; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Parkville, VIC 3000, Australia., Williams SG; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.; Division of Radiation Oncology, Peter MacCallum Cancer Centre, Parkville, VIC 3000, Australia., Keam SP; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Haupt Y; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Haupt S; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.; Tumour Suppression and Cancer Sex Disparity Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.
Publikováno v: Cancers [Cancers (Basel)] 2022 Aug 16; Vol. 14 (16). Date of Electronic Publication: 2022 Aug 16.
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
A defective splicing machinery promotes senescence through MDM4 alternative splicing.
Autor: Deschênes, Mathieu1 (AUTHOR), Durand, Mathieu1 (AUTHOR), Olivier, Marc‐Alexandre2,3 (AUTHOR), Pellerin‐Viger, Alicia2,3 (AUTHOR), Rodier, Francis2,3,4 (AUTHOR), Chabot, Benoit1 (AUTHOR) benoit.chabot@usherbrooke.ca
Publikováno v: Aging Cell. Nov2024, Vol. 23 Issue 11, p1-17. 17p.
Zobrazit plný text záznamu
10
Akademický článek
The Role of Microvascular Variations in the Process of Intervertebral Disk Degeneration and Its Regulatory Mechanisms: A Literature Review.
Autor: Zhang, Si‐Ping1,2 (AUTHOR), Tong, Min1,2 (AUTHOR), Li, Shi‐Da1,2 (AUTHOR), Zhang, Bin1,2 (AUTHOR), Zhang, Wenhao1,2 (AUTHOR), Wang, Rong1,2 (AUTHOR), Dong, Zhen‐Yu1,2 (AUTHOR), Huang, Yi‐Fei1,2 (AUTHOR) jerkhuang@163.com
Publikováno v: Orthopaedic Surgery. Nov2024, Vol. 16 Issue 11, p2587-2597. 11p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje